Cargando…
(18)F-FDG and (18)F-FLT-PET Imaging for Monitoring Everolimus Effect on Tumor-Growth in Neuroendocrine Tumors: Studies in Human Tumor Xenografts in Mice
INTRODUCTION: The mTOR inhibitor everolimus has shown promising results in some but not all neuroendocrine tumors. Therefore, early assessment of treatment response would be beneficial. In this study, we investigated the in vivo and in vitro treatment effect of everolimus in neuroendocrine tumors an...
Autores principales: | Bardram Johnbeck, Camilla, Munk Jensen, Mette, Haagen Nielsen, Carsten, Fisker Hag, Anne Mette, Knigge, Ulrich, Kjaer, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953383/ https://www.ncbi.nlm.nih.gov/pubmed/24626055 http://dx.doi.org/10.1371/journal.pone.0091387 |
Ejemplares similares
-
[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice
por: Jensen, Mette Munk, et al.
Publicado: (2013) -
[18F]FLT and [18F]FDG PET for Non-invasive Treatment Monitoring of the Nicotinamide Phosphoribosyltransferase Inhibitor APO866 in Human Xenografts
por: Munk Jensen, Mette, et al.
Publicado: (2013) -
Early Detection of Response to Experimental Chemotherapeutic Top216 with [(18)F]FLT and [(18)F]FDG PET in Human Ovary Cancer Xenografts in Mice
por: Munk Jensen, Mette, et al.
Publicado: (2010) -
(18)F-FDG PET Imaging of Murine Atherosclerosis: Association with Gene Expression of Key Molecular Markers
por: Hag, Anne Mette Fisker, et al.
Publicado: (2012) -
Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by (18)F-FDG-microPET or external caliper
por: Jensen, Mette Munk, et al.
Publicado: (2008)